| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16.10. | IXICO plc - Trading Update | - | RNS | ||
| IXICO Aktie jetzt für 0€ handeln | |||||
| 15.10. | Ixico secures two agreements worth £1.2m | 2 | Sharecast | ||
| 15.10. | IXICO plc - New contract win and contract extension | - | RNS | ||
| 30.09. | IXICO plc - Notice of Capital Markets Day | - | RNS | ||
| 12.08. | IN BRIEF: Ixico wins neuroimaging contracts worth over PS1 million | 1 | Alliance News | ||
| 12.08. | IXICO plc - Contract Win | - | RNS | ||
| 22.07. | IXICO plc - Strategic Data Partnership with GAP | 2 | RNS | ||
| 17.07. | Ixico flags better-than-expected full-year revenue | 4 | Sharecast | ||
| 17.07. | IXICO plc - Trading Update | - | RNS | ||
| 13.06. | IXICO vergibt Aktienoptionen an Führungskräfte im Rahmen der Mitarbeiterbindungsstrategie | 2 | Investing.com Deutsch | ||
| 13.06. | IXICO plc - Share option awards and PDMR Dealing | 1 | RNS | ||
| 10.06. | IXICO plc - FDA Clearance of Alzheimer's Diagnostic Biomarker | - | RNS | ||
| 20.05. | IXICO plc - Half-year Report | - | RNS | ||
| 06.05. | IXICO plc - Notice of Interim Results & Investor Presentation | - | RNS |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 45,405 | -0,55 % | Konzernbeben: Paukenschlag bei Novo Nordisk: Der halbe Aufsichtsrat schmeißt hin! | © Foto: SOPA Images - Sipa USANach dem offenen Streit mit der Novo Nordisk Foundation treten Aufsichtsratschef Helge Lund und mehrere unabhängige Mitglieder ab. Eine außerordentliche Hauptversammlung... ► Artikel lesen | |
| AURORA CANNABIS | 4,340 | -0,80 % | Aurora Cannabis Inc (3): Aurora Cannabis to issue Q2 fiscal 2026 results Nov. 5 | ||
| CANOPY GROWTH | 1,134 | +0,35 % | Stocks in Play: Canopy Growth Corporation | ||
| HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
| TILRAY BRANDS | 1,267 | +0,68 % | Tilray Brands-Aktie sorgt für Gesprächsstoff - was Anleger jetzt genau verfolgen müssen! | ||
| VERTEX PHARMACEUTICALS | 361,00 | +0,01 % | Vertex Pharmaceuticals Incorporated: Vertex Presents New Data Across Portfolio of Cystic Fibrosis Medicines Including ALYFTREK at the North American Cystic Fibrosis Conference | - Data presented on outcomes following treatment with CFTR modulators add to growing body of evidence that reduced level of sweat chloride is associated with improved clinical outcomes, particularly... ► Artikel lesen | |
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | CSE Bulletin: Suspensions - Blender Bites Limited, TAAT Global Alternatives Inc. | Toronto, Ontario--(Newsfile Corp. - Le 16 mai/May 2025) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as... ► Artikel lesen | |
| MPH HEALTH CARE | 17,600 | -0,85 % | Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH): Kaufen | Original-Research: MPH Health Care AG - from First Berlin Equity Research GmbH
18.09.2025 / 16:25 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer... ► Artikel lesen | |
| CRONOS GROUP | 2,168 | +1,98 % | Cronos Group Inc: Cronos Group to hold Q3 2025 results call Nov. 6 | ||
| SYNBIOTIC | 2,600 | +0,19 % | EQS-News: SYNBIOTIC SE: SYNBIOTIC begrüßt Antrag der Grünen zum Nutzhanfliberalisierungsgesetz und fordert Sachlichkeit in der Medizinalcannabis-Debatte | EQS-News: SYNBIOTIC SE
/ Schlagwort(e): Stellungnahme
SYNBIOTIC begrüßt Antrag der Grünen zum Nutzhanfliberalisierungsgesetz und fordert Sachlichkeit in der Medizinalcannabis-Debatte... ► Artikel lesen | |
| EYEPOINT PHARMACEUTICALS | 10,300 | -0,91 % | EyePoint Pharmaceuticals, Inc.: EyePoint Announces Pivotal Phase 3 Program Initiation for DURAVYU in Diabetic Macular Edema | - DURAVYU now in Phase 3 for the two largest, multi-billion-dollar retinal disease markets, wet AMD and DME with first patient dosing in pivotal Phase 3 DME trials anticipated in Q1 2026 - - New preclinical... ► Artikel lesen | |
| WPD PHARMACEUTICALS | 0,002 | 0,00 % | WPD Pharmaceuticals Inc (2): WPD Pharmaceuticals suspended by CSE | ||
| ORGANIGRAM GLOBAL | 1,400 | -4,76 % | ORGANIGRAM GLOBAL INC. - 6-K, Report of foreign issuer | ||
| GREEN THUMB INDUSTRIES | 6,290 | +1,21 % | Green Thumb Industries Inc: Green Thumb Industries to release Q3 results Nov. 5 | ||
| SNDL | 1,900 | -1,45 % | SNDL Inc.: SNDL Announces 2025 Annual and Special Meeting Results | EDMONTON, AB, July 31, 2025 /PRNewswire/ - SNDL Inc. (NASDAQ: SNDL) (CSE: SNDL) ("SNDL" or the "Company") is pleased to announce the resolutions put to holders... ► Artikel lesen |